Both Semaglutide and the drug represent innovative strategies to treating glucose control, and increasingly, excess weight. Tirzepatide is a dual agonist that targets multiple receptors involved in glucose regulation: https://bookmarkingbay.com/story22142440/grasping-tirzepatide-and-mounjaro-the-detailed-explanation